Autori: Chertkoff Raul
| Naslov | Long-term efficacy and safety results of taliglucerase alfa through 5 years in adult treatment-naive patients with Gaucher disease (Article) |
| Autori | Zimran Ari Duran Gloria Giraldo Pilar Rosenbaum Hanna Giona Fiorina Petakov Milan S Terreros Munoz Eduardo Eduardo Solorio-Meza Sergio Cooper Peter A Varughese Sheeba Alon Sari Chertkoff Raul |
| Info | BLOOD CELLS MOLECULES AND DISEASES, (2019), vol. 78 br. , str. 14-21 |
| Projekat | Protalix BioTherapeutics; Pfizer |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
     |
| Naslov | Long-term safety and efficacy of taliglucerase alfa in pediatric Gaucher disease patients who were treatment-naive or previously treated with imiglucerase (Article) |
| Autori | Zimran Ari Gonzalez-Rodriguez Derlis Emilio Abrahamov Aya Cooper Peter A Varughese Sheeba Giraldo Pilar Petakov Milan S Tan Ee Shien Chertkoff Raul |
| Info | BLOOD CELLS MOLECULES AND DISEASES, (2018), vol. 68 br. , str. 163-172 |
| Projekat | Protalix BioTherapeutics; Pfizer |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
|
| Naslov | Enzyme replacement therapy with taliglucerase alfa: 36-month safety and efficacy results in adult patients with Gaucher disease previously treated with imiglucerase (Article) |
| Autori | Pastores Gregory M Shankar Suma P Petakov Milan S Giraldo Pilar Rosenbaum Hanna Amato Dominick J Szer Jeffrey Chertkoff Raul Brill-Almon Einat Zimran Ari |
| Info | AMERICAN JOURNAL OF HEMATOLOGY, (2016), vol. 91 br. 7, str. 661-665 |
| Projekat | Protalix BioTherapeutics; Pfizer |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
|
| Naslov | Long-term efficacy and safety results of taliglucerase alfa up to 36 months in adult treatment-naive patients with Gaucher disease (Article) |
| Autori | Zimran Ari Duran Gloria Mehta Atul Giraldo Pilar Rosenbaum Hanna Giona Fiorina Amato Dominick J Petakov Milan S Munoz Eduardo Terreros Solorio-Meza Sergio Eduardo Cooper Peter A Varughese Sheeba Chertkoff Raul Brill-Almon Einat |
| Info | AMERICAN JOURNAL OF HEMATOLOGY, (2016), vol. 91 br. 7, str. 656-660 |
| Projekat | Protalix BioTherapeutics; Pfizer |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
|
| Naslov | A Phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucerase alfa, a plant cell-expressed recombinant human glucocerebrosidase, in adult and pediatric patients with Gaucher disease previously treated with imiglucerase (Article) |
| Autori | Pastores Gregory M Petakov Milan S Giraldo Pilar Rosenbaum Hanna Szer Jeffrey Deegan Patrick B Amato Dominick J Mengel Eugen Tan Ee Shien Chertkoff Raul Brill-Almon Einat Zimran Ari |
| Info | BLOOD CELLS MOLECULES AND DISEASES, (2014), vol. 53 br. 4, str. 253-260 |
| Projekat | Protalix BioTherapeutics; Pfizer |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
|
| Naslov | Taliglucerase alfa leads to favorable bone marrow responses in patients with type I Gaucher disease (Article) |
| Autori | van Dussen Laura Zimran An Akkerman EM Aerts JMFG Petakov Milan S Elstein Deborah Rosenbaum H Aviezer David Brill-Almon Einat Chertkoff Raul Maas M Hollak CEM |
| Info | BLOOD CELLS MOLECULES AND DISEASES, (2013), vol. 50 br. 3, str. 206-211 |
| Projekat | Protalix Biotherapeutics |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
|
